You can:
Name | Cysteinyl leukotriene receptor 1 |
---|---|
Species | Homo sapiens (Human) |
Gene | CYSLTR1 |
Synonym | LTD4 receptor LTD4 leukotriene D4 receptor HMTMF81 HG55 [ Show all ] |
Disease | N/A |
Length | 337 |
Amino acid sequence | MDETGNLTVSSATCHDTIDDFRNQVYSTLYSMISVVGFFGNGFVLYVLIKTYHKKSAFQVYMINLAVADLLCVCTLPLRVVYYVHKGIWLFGDFLCRLSTYALYVNLYCSIFFMTAMSFFRCIAIVFPVQNINLVTQKKARFVCVGIWIFVILTSSPFLMAKPQKDEKNNTKCFEPPQDNQTKNHVLVLHYVSLFVGFIIPFVIIIVCYTMIILTLLKKSMKKNLSSHKKAIGMIMVVTAAFLVSFMPYHIQRTIHLHFLHNETKPCDSVLRMQKSVVITLSLAASNCCFDPLLYFFSGGNFRKRLSTFRKHSLSSVTYVPRKKASLPEKGEEICKV |
UniProt | Q9Y271 |
Protein Data Bank | N/A |
GPCR-HGmod model | Q9Y271 |
3D structure model | This predicted structure model is from GPCR-EXP Q9Y271. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL1798 |
IUPHAR | 269 |
DrugBank | BE0000705 |
Name | CHEMBL131287 |
---|---|
Molecular formula | C28H20N6O4 |
IUPAC name | 4-oxo-N-[[4-(quinolin-2-ylmethoxy)phenyl]methyl]-2-(2H-tetrazol-5-yl)chromene-8-carboxamide |
Molecular weight | 504.506 |
Hydrogen bond acceptor | 8 |
Hydrogen bond donor | 2 |
XlogP | 3.3 |
Synonyms | 4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromene-8-carboxylic acid 4-(quinolin-2-ylmethoxy)-benzylamide BDBM50084793 4-oxo-N-(4-(quinolin-2-ylmethoxy)benzyl)-2-(1H-tetrazol-5-yl)-4H-chromene-8-carboxamide |
Inchi Key | CHNHDJKUMQWGKG-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C28H20N6O4/c35-24-14-25(27-31-33-34-32-27)38-26-21(24)5-3-6-22(26)28(36)29-15-17-8-12-20(13-9-17)37-16-19-11-10-18-4-1-2-7-23(18)30-19/h1-14H,15-16H2,(H,29,36)(H,31,32,33,34) |
PubChem CID | 44352397 |
ChEMBL | CHEMBL131287 |
IUPHAR | N/A |
BindingDB | 50084793 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
IC50 | 86.0 nM | PMID20621485 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417